Balyasny Asset Management’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-431,678
Closed -$12.8M 3632
2025
Q3
$12.8M Sell
431,678
-548,010
-56% -$12.7M 0.02% 930
2025
Q2
$23.1M Buy
979,688
+930,398
+1,888% +$19.4M 0.03% 614
2025
Q1
$892K Buy
+49,290
New +$968K ﹤0.01% 2046
2024
Q4
Sell
-31,487
Closed -$462K 3347
2024
Q3
$462K Sell
31,487
-344,984
-92% -$4.32M ﹤0.01% 2287
2024
Q2
$4.28M Sell
376,471
-68,085
-15% -$743K 0.01% 1242
2024
Q1
$4.83M Buy
+444,556
New +$4.44M 0.01% 1236

Other funds holding BTSG

Balyasny Asset Management's BTSG Position: Q4 2025 in Review

Balyasny Asset Management sold out of BrightSpring Health Services (BTSG) in Q4 2025, closing a stake of 431,678 shares — an estimated $12.8M sold.

Balyasny Asset Management first reported a position in BTSG in Q1 2024 and held it in 6 quarters. The position peaked at $23.1M in Q2 2025. 285 funds tracked by Wall St. Rank hold BTSG as of Q4 2025.

  • Balyasny Asset Management reported no remaining BrightSpring Health Services position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 431,678 BrightSpring Health Services shares in Q4 2025, an estimated $12.8M.
  • Balyasny Asset Management first reported a position in BrightSpring Health Services in Q1 2024 and held it in 6 quarters.
  • Balyasny Asset Management's BrightSpring Health Services position peaked at $23.1M in Q2 2025.
  • 285 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.